HCA Healthcare’s (HCA) “Outperform” Rating Reiterated at Royal Bank Of Canada

Royal Bank Of Canada reaffirmed their outperform rating on shares of HCA Healthcare (NYSE:HCA) in a report issued on Monday morning,Benzinga reports. They currently have a $435.00 price objective on the stock.

HCA has been the subject of a number of other research reports. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Oppenheimer decreased their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday. Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Argus decreased their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Finally, JPMorgan Chase & Co. cut their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $465.05.

HCA Healthcare Trading Down 2.3%

NYSE:HCA opened at $408.39 on Monday. The stock has a fifty day moving average price of $386.80 and a 200 day moving average price of $452.03. HCA Healthcare has a 12-month low of $342.71 and a 12-month high of $556.52. The firm has a market cap of $90.60 billion, a PE ratio of 13.67, a price-to-earnings-growth ratio of 1.46 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the company earned $6.84 EPS. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. Equities analysts forecast that HCA Healthcare will post 29.38 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC raised its holdings in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the last quarter. Jump Financial LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at approximately $2,073,000. Finally, Sei Investments Co. grew its stake in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
• Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
• Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
• Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
• Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
• Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.